Últimos testes

EudraCT Number: 2004-004391-36 Sponsor Protocol Number: AC-052-402 Start Date: 2005-05-23
Sponsor Name: Actelion Pharmaceuticals Ltd.
Full Title: A multicenter, open-label, single-arm safety study to investigate the effects of chronic TRACLEER® treatment on testicular function in male patients with pulmonary arterial hypertension
Medical condition: Many endothelin receptor antagonists have profound effects on the histology and function of the testes in animals. These drugs have been shown to induce atrophy of the seminiferous tubules of the t...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male
Trial protocol: HU (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-002096-16 Sponsor Protocol Number: 01/04 Start Date: 2005-05-23
Sponsor Name: Universitätskinderklinik Innsbruck
Full Title: Effect of plasma volume expansion with hydroxy-ethyl-starch (HES) 130/0.4 or crystalloids on interstitial fluid accumulation and blood pressure in newborn infants with arterial hypotension
Medical condition: Arterial hypotension
Disease: Version SOC Term Classification Code Term Level
Population Age: Preterm newborn infants, Newborns, Under 18 Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-002854-78 Sponsor Protocol Number: BO17706 Start Date: 2005-05-23
Sponsor Name: F. Hoffmann-La Roche Ltd.
Full Title: A randomised, double blind, placebo controlled, multicentre phase III trial to evaluate the efficacy and safety of adding bevacizumab to gemcitabine and erlotinib in patients with metastatic pancre...
Medical condition: Metastatic pancreatic cancer (adenocarcinoma)
Disease: Version SOC Term Classification Code Term Level
PT 10033610 7.1
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Completed) DE (Completed) FI (Completed) GB (Completed) SE (Completed) CZ (Completed) ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-004124-12 Sponsor Protocol Number: 55730 Start Date: 2005-05-23
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA
Full Title: LACTOBACILLUS REUTERI REUTERIN AS A THERAPEUTIC AGENT IN INFANTILE COLIC A PROSPECTIVE STUDY.
Medical condition: TREATMENT OF INFANTILE COLIC IN BREASTFED INFANTS OF AGE BETWEEN 21 AND 90 DAYS
Disease: Version SOC Term Classification Code Term Level
6.1 10017947 SOC
Population Age: Infants and toddlers, Under 18 Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2005-001041-42 Sponsor Protocol Number: VAC030 Start Date: 2005-05-23
Sponsor Name: University of Oxford
Full Title: Assessment of protection against malaria by sporozoite challenge of healthy adults vaccinated with the virosomal vaccine PEV3A and FP9-MVA ME-TRAP
Medical condition: Plasmodium falciparum malaria
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-004384-29 Sponsor Protocol Number: Levosepsis1 Start Date: 2005-05-23
Sponsor Name: Dr GED DEMPSEY, University Hospital Aintree
Full Title: Double blind randomised controlled trial of Levosimendan versus Dopexamine in septic shock
Medical condition: Septic Shock
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: (No results available)
EudraCT Number: 2004-003985-14 Sponsor Protocol Number: CPR-EFC5816-EN-E01 Start Date: 2005-05-23
Sponsor Name: Sanofi-Synthelabo Research
Full Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial Evaluating the Effect of Two Doses of a Vasopressin V2 Receptor Antagonist (SR121463B) on Serum Sodium in Patients with Dilutional ...
Medical condition: Dilutional hyponatremia excluding chronic syndrome of inappropriate antidiuretic hormone secretion (SIADH) or cirrhosis
Disease: Version SOC Term Classification Code Term Level
7.1 10021038 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) BE (Completed) SE (Completed) DK (Completed)
Trial results: View results
EudraCT Number: 2005-001507-19 Sponsor Protocol Number: 04/5/025 Start Date: 2005-05-22
Sponsor Name: National Children's Hospital & Trinity College Dublin
Full Title: Treatment with recombinant Growth Hormone in Children born Small for Gestational Age (SGA) without Catch-up Growth.
Medical condition: Short stature in children born small for gestational age without catch up growth
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: IE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004512-23 Sponsor Protocol Number: PKU-003 Start Date: 2005-05-22
Sponsor Name: BioMarin Pharmaceutical Inc.
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenoptin in Subjects with Phenylketonuria Who Have Elevated Phenylalanine Levels
Medical condition: Phenylketonuria (PKU)
Disease: Version SOC Term Classification Code Term Level
6.1 10034872
Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: IE (Completed) GB (Completed) DE (Completed) IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-004924-11 Sponsor Protocol Number: SHX0712 Start Date: 2005-05-20
Sponsor Name: ALK-Abelló A/S
Full Title: A multicentre, randomised, double-blind, placebo-controlled parallel group clinical trial to investigate the efficacy and safety of specific sublingual immunotherapy with SLIT One birch in patients...
Medical condition: Desensibilisierung gegenüber Allergenen
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever